Inlybest – Lymphoma & CLL Treatment

oncology  /  Inlybest

Inlybest

Inlybest is a targeted anticancer medication containing axitinib, used for the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). It blocks certain proteins that promote c... Inlybest is a targeted anticancer medication containing axitinib, used for the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). It blocks certain proteins that promote cancer cell growth, slowing disease progression and helping control its course. Inlybest is used under medical supervision and may be part of combination therapy. The medication improves patients’ quality of life and increases remission duration. Read more Hide

• Active ingredient:
  Axitinib
• Manufacturer: Aprazer
• Dosage: 5 mg
• Dosage form: Tablets
• Units per pack: 28
• Delivery across Ukraine
• 100% original product